Federated Hermes, Inc. Precision Biosciences Inc Transaction History

Federated Hermes, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$0.7 - $1.41 $70,477 - $141,961	-100,682 Reduced 93.38%	7,135 $5,000
Q4 2022 Feb 13, 2023	SELL	$0.97 - $45.0 $90,016 - $4.18 Million	-92,801 Reduced 46.26%	107,817 $128,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $315 - $10,567	-259 Reduced 0.13%	200,618 $261,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $20,852 - $60,564	18,133 Added 9.92%	200,877 $321,000
Q1 2022 May 13, 2022	BUY	$2.96 - $7.76 $338,437 - $887,255	114,337 Added 167.14%	182,744 $563,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $208,117 - $327,925	28,124 Added 69.82%	68,407 $507,000
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $137 - $212	-15 Reduced 0.04%	40,283 $465,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $291,940 - $452,923	36,176 Added 877.63%	40,298 $505,000
Q1 2021 May 13, 2021	SELL	$8.57 - $15.79 $5,099 - $9,395	-595 Reduced 12.61%	4,122 $43,000
Q4 2020 Feb 12, 2021	BUY	$5.98 - $12.47 $777 - $1,621	130 Added 2.83%	4,717 $39,000
Q3 2020 Nov 12, 2020	SELL	$4.65 - $8.73 $599 - $1,126	-129 Reduced 2.74%	4,587 $28,000
Q2 2020 Aug 13, 2020	SELL	$4.66 - $8.7 $1,374 - $2,566	-295 Reduced 5.89%	4,716 $39,000
Q1 2020 May 13, 2020	BUY	$5.05 - $15.01 $7,514 - $22,334	1,488 Added 42.24%	5,011 $30,000
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $22,138 - $68,868	-3,503 Reduced 49.86%	3,523 $49,000
Q3 2019 Nov 14, 2019	BUY	$8.03 - $14.82 $56,418 - $104,125	7,026 New	7,026 $59,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.